Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PDCD6 divergent transcript (PDCD6-DT), also referred to as HRAT5, is a long non-coding RNA in humans. While its name reflects its location relative to the protein-coding gene PDCD6 (Programmed Cell Death 6), PDCD6-DT itself does not encode a protein, nor is it recognized as a receptor, enzyme, transporter, or other classical drug target. Very little is currently known about its biological function, molecular mechanisms, or disease associations. There is currently no evidence that PDCD6-DT is directly involved in therapeutic pathways or targeted by drugs. The transcript's annotation reflects emerging interest in non-coding RNAs as potential regulators of gene expression, but conclusive roles for PDCD6-DT have not been established in the literature or major gene databases[1][2][5]. If more detailed mechanistic or functional information becomes available in the future, updates to this profile would be warranted.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PDCD6 divergent transcript (PDCD6-DT).